Todd Billet

Todd Billet has a varied work experience that spans over several companies. Todd has held positions such as Sr. Director Commercial Ops at Blueprint Medicines since January 2022, Director of Field Operations at Blueprint Medicines from August 2019 to December 2021, Associate Director Field Force Effectiveness at Biogen from February 2017 to August 2019, Sr. Manager Field Force Effectiveness at Biogen from January 2016 to February 2017, Sr. Manager Forecasting at Sanofi Genzyme from January 2015 to December 2015, Specialty Sales Representative at Sanofi Genzyme from April 2010 to December 2014, Commercial Operations Analyst at Sanofi Genzyme from June 2007 to April 2010, and Research Analyst at Health Strategies Group from June 2006 to June 2007.

Todd Billet received their BA in Economics from the University of Virginia in 2004. In 2006, they earned an MPH in Health Systems and Policy from the Rutgers Robert Wood Johnson Medical School.